Association between tazobactam-piperacillin exposure and the subsequent emergence in gram-negative rods: Findings

Ezaki Masayoshi1, Kato Noriko2, Nagaoka Kentaro1

  • 1Department of Clinical Infectious Diseases, Toyama University Hospital, Toyama, Japan.

Abstract

Insights

Prolonged exposure to tazobactam-piperacillin (TZP) for 14 days or more increases the risk of developing resistant gram-negative rods (GNRs). Optimizing TZP duration is key to antimicrobial stewardship.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Antimicrobial Resistance

Background:

  • The relationship between tazobactam-piperacillin (TZP) exposure and the development of subsequent antimicrobial resistance is not well understood.
  • Gram-negative rods (GNRs) are a significant cause of hospital-acquired infections, and resistance to commonly used antibiotics like TZP is a growing concern.

Purpose of the Study:

  • To investigate the association between the duration of TZP treatment and the emergence of TZP-resistant GNRs.
  • To identify independent risk factors for the development of TZP resistance in GNRs.

Main Methods:

  • A retrospective observational study was conducted at a single institution.
  • Data from 1,619 patients treated with TZP between January 2021 and December 2023 were analyzed.
  • Multivariable Fine-Gray regression was used to identify risk factors for new TZP-resistant GNRs within 180 days of exposure.

Main Results:

  • 5.9% of patients developed new TZP-resistant GNRs within 180 days.
  • Patients receiving TZP for ≥14 days had a higher cumulative incidence of resistance (12.0%).
  • Prolonged TZP exposure (≥14 days) was an independent risk factor (aSHR 1.73; 95% CI 1.03-2.89).
  • Pseudomonas aeruginosa and AmpC-producing Enterobacterales were common resistant isolates.

Conclusions:

  • Extended TZP treatment duration (≥14 days) is an independent predictor of subsequent TZP-resistant GNR emergence.
  • Initial microbiological findings and specific clinical factors also contribute to resistance development.
  • Antimicrobial stewardship programs should focus on optimizing TZP treatment duration to combat resistance.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...